Cases 11 - 20 of 75
US v. Regeneron Pharmaceuticals, Inc.
as 23-2086
Plaintiff / Appellant:
UNITED STATES
Defendant / Appellee:
REGENERON PHARMACEUTICALS, INC.
Interested Party:
GENENTECH, INC. and ROBERT J. TERIFAY
Regeneron Pharmaceuticals, Inc. v. Formycon AG
as WVN/1:23-CV-00097
Plaintiff:
Regeneron Pharmaceuticals, Inc.
Defendant:
Formycon AG
Regeneron Pharmaceuticals, Inc. v. Formycon AG
as 1:2023cv00097
Plaintiff:
Regeneron Pharmaceuticals, Inc.
Defendant:
Formycon AG
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Regeneron Pharmaceuticals, Inc. v. Samsung Bioepis, CO., LTD.,
as WVN/1:23-CV-00094
Plaintiff:
Regeneron Pharmaceuticals, Inc.
Defendant:
Samsung Bioepis, CO., LTD., and Samsung Bioepis Co., Ltd.
Regeneron Pharmaceuticals, Inc. v. Samsung Bioepis, CO., LTD.,
as 1:2023cv00094
Plaintiff:
Regeneron Pharmaceuticals, Inc.
Defendant:
Samsung Bioepis, CO., LTD.,
Cause Of Action: 35 U.S.C. § 145 Patent Infringement
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc.
as WVN/1:23-CV-00089
Plaintiff:
Regeneron Pharmaceuticals, Inc.
Defendant:
Celltrion, Inc.
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc.
as 1:2023cv00089
Plaintiff:
Regeneron Pharmaceuticals, Inc.
Defendant:
Celltrion, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
US v. Regeneron Pharmaceuticals, Inc.
as 23-8036
Petitioner:
UNITED STATES
Respondent:
REGENERON PHARMACEUTICALS, INC.
In re: Request from South Korea
as 1:2023cv01124
Petitioner:
Regeneron Pharmaceuticals, Inc.
Respondent:
Biogen Inc.
Cause Of Action: 28 U.S.C. § 1782 Letter rogatory - appointment
Michael Krantz et al v. Regeneron Pharmaceuticals, Inc. et al
as 2:2023cv08034
Plaintiff:
Michael Krantz, Lauren Gregory and Joshua Krantz
Defendant:
Regeneron Pharmaceuticals, Inc. and Sanofi Aventis US, LLC
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
